Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 409, pseudogene (RNU6-409P) is a human genomic locus classified as a pseudogene of the U6 small nuclear RNA (U6 snRNA) gene family[4]. The U6 snRNA itself is an essential, highly conserved small nuclear RNA involved as a component of the spliceosome, catalyzing the removal of introns from pre-mRNA in the nucleus of eukaryotic cells[1][3]. However, the suffix “pseudogene” indicates that the specific RNU6-409P locus is a non-functional copy—it is not transcribed into a functional RNA product and is not involved in splicing or other biological processes. Large numbers of U6 pseudogene loci exist in the human genome as a result of retrotransposition or genomic duplication events, none of which have been shown to encode functional spliceosomal RNAs or protein products[3][5]. There is no evidence linking RNU6-409P to any disease, drug interaction, or direct biological function. Pseudogenes such as RNU6-409P are typically considered genomic fossils with no known physiological or pathological role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 409, pseudogene (RNU6-409P).